4//SEC Filing
ALLERGAN INC 4
Accession 0001127602-15-012113
CIK 0000850693operating
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 6:53 PM ET
Size
27.6 KB
Accession
0001127602-15-012113
Insider Transaction Report
Form 4
ALLERGAN INCAGN
BARLOW JAMES F
SR. VP, Corp. Controller (PAO)
Transactions
- Disposition to Issuer
Common Stock
2015-03-17−1,873→ 0 total - Disposition to Issuer
Common Stock
2015-03-17−644.306→ 0 total(indirect: By Trust) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2015-03-17−4,925→ 0 totalExercise: $59.13Exp: 2020-02-22→ Common Stock (4,925 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2015-03-17−14,000→ 0 totalExercise: $105.87Exp: 2023-02-21→ Common Stock (14,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2015-03-17−6,008→ 0 totalExercise: $234.00Exp: 2025-02-20→ Common Stock (6,008 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2015-03-17−1,000→ 0 totalExercise: $105.87Exp: 2023-02-21→ Common Stock (1,000 underlying) - Gift
Common Stock
2015-03-04−3,135→ 1,873 total - Disposition to Issuer
Common Stock
2015-03-17−1,852.326→ 0 total(indirect: By Trust) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2015-03-17−9,500→ 0 totalExercise: $75.58Exp: 2021-02-17→ Common Stock (9,500 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2015-03-17−11,625→ 0 totalExercise: $87.91Exp: 2022-02-17→ Common Stock (11,625 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2015-03-17−11,469→ 0 totalExercise: $125.07Exp: 2024-02-21→ Common Stock (11,469 underlying) - Disposition to Issuer
Restricted Stock Units
2015-03-17−462→ 0 total→ Common Stock (462 underlying)
Footnotes (6)
- [F1]Pursuant to that certain Agreement and Plan of Merger dated November 16, 2014, (the "Merger Agreement") by and among the Issuer, Actavis, Plc ("Actavis) and a wholly-owned subsidiary of Actavis, the Issuer became an indirect wholly-owned subsidiary of Actavis upon consummation of the merger (the "Effective Date"). Each share of common stock was disposed of in exchange for $129.22 cash plus 0.3683 of an Actavis ordinary share, having a market value of $307.51 per share on the Effective Date.
- [F2]The option originally covered 19,700 shares of which 14,755 shares subject to the option were exercised prior to the Effective Date.
- [F3]Each option vested in full on the Effective Date and was cancelled in exchange for a cash payment equal to the number of shares subject to the option immediately prior to the merger, multiplied by the difference between (i) 0.3683 times $294.1509 (which represents the 10-day volume weighted average price of Actavis stock starting on the 11th trading day prior to the closing) plus $129.22 and (ii) the exercise price of the option, subject to the applicable withholding taxes and pursuant to the procedures set forth in the Merger Agreement.
- [F4]The option originally covered 19,000 shares of which 9,500 shares subject to the option were exercised prior to the Effective Date.
- [F5]The option originally covered 15,500 shares of which 3,875 shares subject to the option were exercised prior to the Effective Date.
- [F6]The restricted stock units ("RSUs") vested in full on the Effective Date and each RSU was cancelled in exchange for 0.3683 shares of Actavis stock having a market value of $307.51 per share on the Effective Date, and $129.22 in cash.
Documents
Issuer
ALLERGAN INC
CIK 0000850693
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000850693
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 6:53 PM ET
- Size
- 27.6 KB